Expertise in
2
conditions

Johannes C. Doescher

Augsburg, BY, DE 
Expertise in
2
conditions
Augsburg, BY, DE 

Overview

Johannes Doescher practices practicing medicine in Augsburg, Germany.

Mr. Doescher is highly rated in 2 conditions, according to our data. His clinical expertise encompasses Head and Neck Squamous Cell Carcinoma (HNSCC), Sinus Cancer, NUT Carcinoma, and Simpson-Golabi-Behmel Syndrome.

He is actively involved in clinical research, co-authoring 68 peer reviewed articles and participating in 1 clinical trial.

Gender

Male

Locations

Augsburg, BY, Germany
Other Locations
Head And Neck Surgery, Ulm, BW, Germany
Nasen‑, Ohrenheilkunde, Kopf Und Halschirurgie, Kerpener Str. 62, Deutschland, Koeln, NW 50937, Germany
Department Of Otolaryngology Head And Neck Surgery, Ulm, Salem, BW, Germany
Department Of Otolaryngology Head And Neck Surgery, Munich, BY 81675, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Randomized, Double-Blind, Adaptive, Phase II/III Study of GSK3359609 in Combination With Pembrolizumab and 5FU-Platinum Chemotherapy Versus Placebo in Combination With Pembrolizumab Plus 5FU-Platinum Chemotherapy for First-Line Treatment of Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
A Randomized, Double-Blind, Adaptive, Phase II/III Study of GSK3359609 in Combination With Pembrolizumab and 5FU-Platinum Chemotherapy Versus Placebo in Combination With Pembrolizumab Plus 5FU-Platinum Chemotherapy for First-Line Treatment of Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
Enrollment Status: Terminated
Publish Date: October 09, 2024
Intervention Type: Drug
Study Drugs: Feladilimab, Pembrolizumab, Fluorouracil, Cisplatin, Carboplatin
Study Phase: Phase 3

68 Total Publications

ASO Visual Abstract: Sentinel Node Biopsy in the Neck Management of cN0 Sinonasal Squamous Cell Carcinoma-A Multicenter Pilot Trial on Safety and Feasibility.
ASO Visual Abstract: Sentinel Node Biopsy in the Neck Management of cN0 Sinonasal Squamous Cell Carcinoma-A Multicenter Pilot Trial on Safety and Feasibility.
Journal: Annals of surgical oncology
Published: June 30, 2026

Frequently Asked Questions about Johannes C. Doescher

Is Johannes C. Doescher a top-rated expert for Head and Neck Squamous Cell Carcinoma (HNSCC)?

MediFind is an objective health platform that identifies experts based on real-world data. Johannes C. Doescher is classified as an Distinguished expert for Head and Neck Squamous Cell Carcinoma (HNSCC), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Johannes C. Doescher participate in research or clinical trials?

Yes. Johannes C. Doescher has published 68 articles and abstracts on conditions like Head and Neck Squamous Cell Carcinoma (HNSCC). You can view a list of Johannes C. Doescher's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Doescher's expertise for a condition
ConditionClose
    View All 11 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile